Oxybutynin Chloride
Product Images NDC 10135-640
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 10135-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers. (Oxybutynin Chloride Tablets 02)
Figure 2. Mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5 To 15 Years Of Age. – Plot Represents All Available Data Normalized To The Equivalent Of Oxybutynin Chloride 5 mg Bid Or Tid At Steady State (Oxybutynin Chloride Tablets 03)
Ndc 10135-0640-01marlexpharmaceuticals, Inc.oxybutyninchloride Tablets, Usp5 mgrx Only 100 Tablets (Oxybutynin Chloride Tablets 04)
Oxybutynin Chloride Tablets 05
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.